Back to top
Top

All eCQMs associated with PCPI(R) Foundation (PCPI[R])

Year Type CMS eCQM ID Measure Name
2021 EP/EC CMS129v10 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2018 EP/EC CMS129v7 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2019 EP/EC CMS129v8 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2020 EP/EC CMS129v9 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2018 EP/EC CMS132v6 Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
2019 EP/EC CMS132v7 Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
2018 EP/EC CMS133v6 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2019 EP/EC CMS133v7 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2020 EP/EC CMS133v8 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2021 EP/EC CMS133v9 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2018 EP/EC CMS135v6 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2019 EP/EC CMS135v7 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2020 EP/EC CMS135v8 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2021 EP/EC CMS135v9 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2018 EP/EC CMS138v6 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
2019 EP/EC CMS138v7 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
2020 EP/EC CMS138v8 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
2021 EP/EC CMS138v9 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
2018 EP/EC CMS142v6 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
2019 EP/EC CMS142v7 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care